CJC-1295 5mg + IPA 5mg

  • Batch and lot coded with publicly visible lab reports to ensure quality and transparency.
  • Free of adulterants, excipients and flow agents to ensure purity.
  • Tamper-proof seal to ensure safety in transit.
  • RTF vials are Washed, Depyrogented, and ETO Sterilized.
  • Aliquot injectable vials are fully sterilized and filtered.

$79.95

Range Discount
1 - 3 $79.95
4 - 6 $71.96
7 - 10 $67.96
11 - 15 $63.96
16 - 25 $62.36
26 - 30 $59.96
31 + $55.97
11 People watching this product now!

Payment Methods:

Bitcoin
Chemical Storage

Chemical Information

Chemical Information

Cas Number
863288-34-0 + 170851-70-4
PubChem CID
56841945
Molecular Weight
3367.9 g/mol
Molecular Formula
C152H252N44O42
Synonyms
C152H252N44O42

Storage (Lyophilized)

Lab Results

Dates

Date Added:

08/15/2025

Janoshik Lab Results
Avg. Purity:

99%

Avg. Mass:

4.99mg & 5.46mg

Date:

08/15/2025

Description

CJC-1295 + Ipamorelin Blend – 5mg/5mg | Buy CJC IPA Stack USA & Canada

The CJC-1295 + Ipamorelin blend (5mg/5mg) is a widely studied peptide combination designed for research involving growth hormone (GH) release, recovery, and metabolic function. This stack combines two complementary compounds that work through different mechanisms to stimulate GH secretion in research environments.

At StrateLabs, this peptide blend is supplied with high purity and consistency to ensure reliable research outcomes. Customers looking to buy CJC-1295 and Ipamorelin online in the USA or Canada benefit from fast shipping, secure packaging, and a streamlined ordering experience.

Key Features & Highlights

  • Combination of CJC-1295 and Ipamorelin peptides
  • Designed for synergistic GH release research
  • Commonly studied for recovery, growth, and metabolic analysis
  • Balanced 5mg/5mg formulation
  • High-purity blend for consistent research applications

Research Applications

The CJC-1295 and Ipamorelin combination is frequently used in research focused on growth hormone stimulation and endocrine system regulation. CJC-1295 acts as a GHRH analog, promoting GH release, while Ipamorelin works as a ghrelin receptor agonist, enhancing GH secretion through a complementary pathway.

This dual mechanism allows researchers to study more sustained and efficient GH release patterns compared to single-compound applications. The blend is commonly included in research examining muscle development, fat metabolism, recovery processes, and hormonal balance.